GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lionco Pharmaceutical Group Co Ltd (SHSE:603669) » Definitions » Securities & Investments

Lionco Pharmaceutical Group Co (SHSE:603669) Securities & Investments


View and export this data going back to 2015. Start your Free Trial

What is Lionco Pharmaceutical Group Co Securities & Investments?

Securities & Investments only applies to banks.


Lionco Pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
No. 20, National Highway 349, Naidong District, Shannan, CHN
Lionco Pharmaceutical Group Co Ltd is engaged in the research and development of medicines. The product portfolio includes - Alanyl glutamine for injection, fructose for injection, inverted sugar for injection, xylitol for injection, riboflavin sodium phosphate for injection, and water-soluble vitamin for injection.
Executives
Zhang Jun Ke Director
Wang Wen Nan Director
Tao Xiao Gang Director
Tao Ling Gang Director
Tao Ling Ping Director